Known as the President's Emergency Plan for Aids Relief (Pepfar), it led to the investment of more than $100bn (£74bn) in the ...

In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care   The Big Story Global HIV program a ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

The Joint United Nations Programme on HIV/Aids (UNAIDS) has today released a report that highlights a significant funding crisis threatening years of progress in the fight against HIV/Aids.The 2025 ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

People living with HIV face unique oral health challenges that require special attention and care. The virus's impact on the ...

UN says if US funding for HIV programs is not replaced, millions more will die by 2029 ...

Until recently, the UN was on track to meet its target of ending AIDS as a public health threat by 2030. But with the U.S.